Combination of Diet and Oral Budesonide for Ulcerative Colitis
Status:
Not yet recruiting
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
The ReDUCE Trial is a multinational single-blinded randomized controlled trial in mild to
moderate flare of Ulcerative colitis (UC) disease patients. The purpose of the study is to
validate the clinical efficacy of the UCED (Ulcerative colitis Exclusion Diet) with partial
enteral nutrition (PEN) using a novel formula.
The investigators anticipate that adding a novel specifically designed dietary intervention
in addition to drug will lead to superior remission and mucosal healing via changes in the
microbiome.